Use of Biologic Extracellular Matrix in Two Ways to Reduce Cardiac Electronic Device Infection-Reference-Cited by-同舟云学术

Use of Biologic Extracellular Matrix in Two Ways to Reduce Cardiac Electronic Device Infection

Published:2021-01-31 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Buchanan Emily,Yoo Dale

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference19 articles.

1. Prevention of cardiac implantable electronic device infections: update and evaluation of the potential role for capsulectomy or the antibiotic pouch;Gleva MJ;J Atr Fibrillation,2017

2. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry;Poole JE;Circulation,2010

3. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003;Voigt A;J Am Coll Cardiol,2006

4. Temporal trends in permanent pacemaker implantation: a population-based study;Uslan DZ;Am Heart J,2008

5. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999;Cabell CH;Am Heart J,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of device‐related infections in patients with cancer: Current practice and future horizons;CA: A Cancer Journal for Clinicians;2022-09-23

2. Risk Profiles and Outcomes of Patients Receiving Cardiovascular Implantable Electronic Devices With and Without Antibacterial Envelopes;Cureus;2022-05-04

3. Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis;World Journal of Cardiology;2022-03-26